The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel ...

Kytopen, a provider of continuous flow cellular engineering technologies, has collaborated with BlueWhale Bio to advance the ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

The study will interest researchers studying genome organisation in mitosis. Genomes assume a complex 3D architecture in the interphase cell nucleus. Yet, the molecular mechanisms that determine ...

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on ...

Kytopen Corp., a leader in providing continuous flow cellular engineering technologies, announced today its collaboration with BlueWhale Bio, Inc., a company dedicated to accelerating the growth and ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Cell Therapy Raw Materials Market Through 2025? There has been a significant increase ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.